Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Judson

Showing results (31-40 of 111) with videos related to

Pageof 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
High-dose busulfan in patients with myelomaJ Mansi, F da Costa, C Viner, et al.
British Journal of Cancer|October 1, 1990
The value of computed tomographic (CT) scan surveillance in the detection and management of brain metastases in patients with small cell lung cancerJ Hardy, I Smith, G Cherryman, et al.
Cancer Chemotherapy and Pharmacology|July 8, 1998
Phase I study of oral JM216 given twice dailyP Beale, F Raynaud, J Hanwell, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 25, 2004
Treatment of uterine sarcoma at the Royal Marsden Hospital from 1974 to 1998L Livi, E Andreopoulou, N Shah, et al.
British Journal of Cancer|March 20, 2008
Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experienceH-T Arkenau, D Olmos, J E Ang, et al.
Journal of Molecular Evolution|February 25, 2012
Nucleotide composition of CO1 sequences in Chelicerata (Arthropoda): detecting new mitogenomic rearrangementsJuliette Arabi, Mark L I Judson, Louis Deharveng, et al.
Gynecologic Oncology|October 27, 2006
Participation of patients with gynecological cancer in phase I clinical trials: two years experience in a major cancer centerF Legge, D Eaton, R Molife, et al.
Oncology Reports|May 20, 2011
Antitumor effect of trimelamol against human breast carcinoma xenografts in nude miceY Yamada, T Kubota, Y Hoshiya, et al.
Cancer Chemotherapy and Pharmacology|June 10, 1998
Metabolism, excretion and pharmacokinetics of a single dose of [14C]-raltitrexed in cancer patientsP Beale, I Judson, J Hanwell, et al.
Cancer Chemotherapy and Pharmacology|December 4, 2009
A phase I dose-escalation and bioavailability study of oral and intravenous formulations of erlotinib (Tarceva, OSI-774) in patients with advanced solid tumors of epithelial originM Ranson, H Shaw, J Wolf, et al.
Pageof 12

Showing results (31-40 of 111) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
High-dose busulfan in patients with myelomaJ Mansi, F da Costa, C Viner, et al.
British Journal of Cancer|October 1, 1990
The value of computed tomographic (CT) scan surveillance in the detection and management of brain metastases in patients with small cell lung cancerJ Hardy, I Smith, G Cherryman, et al.
Cancer Chemotherapy and Pharmacology|July 8, 1998
Phase I study of oral JM216 given twice dailyP Beale, F Raynaud, J Hanwell, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 25, 2004
Treatment of uterine sarcoma at the Royal Marsden Hospital from 1974 to 1998L Livi, E Andreopoulou, N Shah, et al.
British Journal of Cancer|March 20, 2008
Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experienceH-T Arkenau, D Olmos, J E Ang, et al.
Journal of Molecular Evolution|February 25, 2012
Nucleotide composition of CO1 sequences in Chelicerata (Arthropoda): detecting new mitogenomic rearrangementsJuliette Arabi, Mark L I Judson, Louis Deharveng, et al.
Gynecologic Oncology|October 27, 2006
Participation of patients with gynecological cancer in phase I clinical trials: two years experience in a major cancer centerF Legge, D Eaton, R Molife, et al.
Oncology Reports|May 20, 2011
Antitumor effect of trimelamol against human breast carcinoma xenografts in nude miceY Yamada, T Kubota, Y Hoshiya, et al.
Cancer Chemotherapy and Pharmacology|June 10, 1998
Metabolism, excretion and pharmacokinetics of a single dose of [14C]-raltitrexed in cancer patientsP Beale, I Judson, J Hanwell, et al.
Cancer Chemotherapy and Pharmacology|December 4, 2009
A phase I dose-escalation and bioavailability study of oral and intravenous formulations of erlotinib (Tarceva, OSI-774) in patients with advanced solid tumors of epithelial originM Ranson, H Shaw, J Wolf, et al.
Pageof 12